Innovative Industrial Properties Inc.

Innovative Industrial Properties Inc.

The tremendous momentum of state legalization of medical-use cannabis in the United States has led to a transformation in the way patients can obtain treatment for a wide spectrum of medical conditions in a safe, reliable and compassionate environment, giving hope to millions. Our focus is to partner with well-capitalized, experienced medical-use cannabis growers in states with a robust medical-use regulatory environment. Our acquisition strategy is to act as a source of capital to these licensed medical-use cannabis growers by acquiring and leasing back their real estate locations. By selling the real estate to us, and then leasing it back, growers have the opportunity to redeploy the proceeds into their company’s core operations allowing them to focus their resources on reaching as many patients as possible in need of treatment.
1d 5d 1m 6m 1y Max

Innovative Industrial Properties Inc. News

18 hours ago

Pot's Premier Property Mogul Keeps Finding More Marijuana Opportunities

Cannabis-focused REIT Innovative Industrial Properties has had a prosperous 2019 so far.

16 May

The State Of REITs: May 2019 Edition

REIT Performance REITs have achieved gains in all four months of 2019, with a stellar 18.67% return year to date. REITs (+0.51%) underperformed the broader market in April, falling short of the NASDAQ...

13 May

Hedge Funds Have Never Been More Bullish On Innovative Industrial Properties, Inc. (IIPR)

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors....

10 May

Marijuana REIT Innovative Industrial Posts Triple-Digit Profitability Growth

In the first quarter, AFFO per share -- a key REIT profitability metric -- soared 135% year over year.

08 May

APHA, EMH, GTIBF, and IIPR Lead the Gains in the Cannabis Sector

APHA, EMH, GTIBF, and IIPR Lead the Gains in the Cannabis SectorCannabis sector risesThe overall market sentiment for the cannabis sector appears to have improved after the sell-off in the last few days....

08 May

Innovative Industrial Properties Reports First Quarter 2019 Results

Acquisitions Drive 146% Q1 Rental Revenue, 444% Q1 Net Income and 275% Q1 AFFO Growth Year-over-Year Innovative Industrial Properties, Inc. ("IIP"), the first and only real estate company on the...

05 May

If You Had Bought Innovative Industrial Properties (NYSE:IIPR) Stock A Year Ago, You Could Pocket A 148% Ga

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! When you buy shares in a company, there is always a risk that the price drops...

03 May

What Stocks are on the U.S. Marijuana Index?

The U.S. marijuana index has significantly outperformed the S&P 500, but it also carries additional risks. The marijuana industry is young and stock prices react to government discussion on related policies....

02 May

APHA, CRON, and Other Cannabis Stocks Resume Their Falls

Why CannTrust Is Taking a Hit Today(Continued from Prior Part)Cannabis sector weakensOn May 2, the overall sentiment surrounding the cannabis sector appeared to be negative, with sector ETFs such as the...

29 Apr

Cannabis Sector: Analyzing the Biggest Gains Last Week

Cannabis Sector: Analyzing the Biggest Gains Last WeekWeekly gainersThe week ending April 26 brought some relief to cannabis sector investors. The Horizons Marijuana Life Sciences ETF (HMMJ) rose as much...

Load more

About Innovative Industrial Properties Inc.

In 1996, voters made California the first state in the United States to allow for medical-use cannabis. Over the next twenty years, medical-use cannabis programs have been adopted by over half of the United States, where over 200 million people reside. As of December 31, 2017, 29 states, plus the District of Columbia, have adopted medical-use cannabis programs. This wave of adoption by states of medical-use cannabis programs has been driven by the rapidly evolving, overwhelming acceptance of Americans for medical-use cannabis as an alternative form of treatment for patients. In fact, according to a 2017 poll conducted by Quinnipiac University, 94% of those surveyed support adults being able to use medical cannabis, if recommended by a doctor.
According to The ArcView Group, sales of legal cannabis in North America are expected to grow from $6.8 billion in 2016 to $24.5 billion in 2021, representing a 28% compound annual growth rate. States have authorized numerous medical conditions as qualifying conditions for treatment with medical-use cannabis, which may include, among others, treatment for cancer, glaucoma, HIV/AIDs, wasting syndrome, pain, nausea, seizures, muscle spasms, multiple sclerosis, post-traumatic stress disorder (PTSD), migraines, arthritis, Parkinson's disease, Alzheimer's, lupus, residual limb pain, spinal cord injuries, inflammatory bowel disease and terminal illness. The Marijuana Policy Project estimates that, as of February 2018, an estimated 2.5 million people were registered as patients in states with regulated medical-use cannabis programs.


Alan D. Gold
Executive Chairman
Paul Smithers
Chief Executive Officer, President, and Director
Catherine Hastings
Chief Financial Officer, Chief Accounting Officer...
Brian Wolfe
Vice President, General Counsel and Secretary
Ben Regin
Director of Investments and Finance
Andy Bui
Gary Kreitzer
Vice Chairman
David Stecher
Scott Shoemaker
MD — Director
$ 88.86
Share volume:
15.321 K
Total value:
967.364 K
Market cap:
871.378 M